AML: Postremission clonal hematopoiesis persists even after therapies but has little clinical significanceJune 24, 2021AML
Unconventional NK cells in newly diagnosed AML identifies a subset with adverse clinical outcomesJune 24, 2021AML
AML: Transplantation in the first CR can overcome negative influence of RUNX1 mutationJune 24, 2021AML
rAML: Second HCT requires careful consideration of patient characteristics and outcomes of first transplantJune 24, 2021AML
AML: Autologous fecal microbiota transfer may restore gut microbiota after intensive chemotherapyJune 24, 2021AML
AML: Better prognostic insight with NGS MRD after first consolidation vs. after induction chemotherapyJune 24, 2021AML
Posaconazole prophylaxis reduces breakthrough fungal infections in AML patients receiving induction chemotherapyJune 24, 2021AML
Hematology NewsHMAs benefit children with relapsed/refractory AMLJune 23, 2021AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsReduced-intensity transplant benefits older patients with AMLJune 22, 2021AMLLeukemia, Myelodysplasia, Transplantation
FLT3-mutated AML: FLT3i-based induction and allo-SCT in first remission improves survivalJune 9, 2021AML
